4359 related articles for article (PubMed ID: 3864391)
1. A histological assessment of the four-day subrenal capsule assay (SRCA).
Lévi F; Blum JP; Lemaigre G; Mechkouri M; Roulon A; Mathé G
Ann Chir Gynaecol Suppl; 1985; 199():44-50. PubMed ID: 3864391
[TBL] [Abstract][Full Text] [Related]
2. [Preoperative ultrasonographic measurement of melanoma thickness with 20 MHz probe].
Pennasilico G; Santini A; Bono R; Cacciaguerra MG; Puddu P; Falappa P
Radiol Med; 1994 Oct; 88(4):388-91. PubMed ID: 7997609
[TBL] [Abstract][Full Text] [Related]
3. [Survival rate of young patients with malignant choroidal melanoma after conservative treatment].
Romanowska B; Zygulska-Mach H; Ksiezyk M
Klin Oczna; 1998; 100(4):211-6. PubMed ID: 9770979
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
[TBL] [Abstract][Full Text] [Related]
5. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.
Filshie RJ; Zannettino AC; Makrynikola V; Gronthos S; Henniker AJ; Bendall LJ; Gottlieb DJ; Simmons PJ; Bradstock KF
Leukemia; 1998 Mar; 12(3):414-21. PubMed ID: 9529137
[TBL] [Abstract][Full Text] [Related]
6. Concurrent induction of CD4+ and CD8+ T cells during tumor growth with antitumor reactivity in adoptive immunotherapy.
Arca MJ; Krauss JC; Aruga A; Cameron MJ; Chang AE
J Immunother; 1997 Mar; 20(2):138-45. PubMed ID: 9087386
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma of the skin. Epidemiology, risk factors, clinical diagnosis].
Vosmík F
Cas Lek Cesk; 1996 Jul; 135(13):405-8. PubMed ID: 8925536
[TBL] [Abstract][Full Text] [Related]
8. Malignant cells revealed in fine needle punctures of lymph nodes and tumours by electronmicroscopical methods.
Hulinska D; Bruna J; Smetana K
Cent Eur J Public Health; 1995 Nov; 3(4):195-8. PubMed ID: 8903520
[TBL] [Abstract][Full Text] [Related]
9. Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.
Bernhard H; Maeurer MJ; Jäger E; Wölfel T; Schneider J; Karbach J; Seliger B; Huber C; Storkus WS; Lotze MT; Meyer zum Büschenfelde KH; Knuth A
Scand J Immunol; 1996 Sep; 44(3):285-92. PubMed ID: 8795723
[TBL] [Abstract][Full Text] [Related]
10. Tumor cells engineered to express major histocompatibility complex class II molecules induce T helper cell-dependent responses that protect mice from normally lethal doses of unmodified tumor cells.
Callahan GN; Leach DR
Cancer Detect Prev; 1996; 20(3):199-206. PubMed ID: 8769713
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
12. The National Cancer Data Base. A mechanism for assessment of patient care.
Steele GD; Winchester DP; Menck HR
Cancer; 1994 Jan; 73(2):499-504. PubMed ID: 8293419
[TBL] [Abstract][Full Text] [Related]
13. Metastatic phenotype in hybrid cells derived from B16 melanoma.
Ito M; Izuhara M; Shimizu K; Sekiguchi M
Cancer Lett; 1994 Apr; 78(1-3):33-9. PubMed ID: 8180966
[TBL] [Abstract][Full Text] [Related]
14. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder.
Patard JJ; Brasseur F; Gil-Diez S; Radvanyi F; Marchand M; François P; Abi-Aad A; Van Cangh P; Abbou CC; Chopin D
Int J Cancer; 1995 Feb; 64(1):60-4. PubMed ID: 7665250
[TBL] [Abstract][Full Text] [Related]
15. 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.
Sijens PE; Knopp MV; Brunetti A; Wicklow K; Alfano B; Bachert P; Sanders JA; Stillman AE; Kett H; Sauter R
Magn Reson Med; 1995 Jun; 33(6):818-26. PubMed ID: 7651119
[TBL] [Abstract][Full Text] [Related]
16. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
Loveland BE; McKenzie IF
Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
[TBL] [Abstract][Full Text] [Related]
17. [Melanoma and dysplastic nevus after 8 years of topical Caryolysine].
Cosnes A; Revuz J; Wechsler J; Touraine R
Ann Dermatol Venereol; 1984; 111(2):127-32. PubMed ID: 6721359
[TBL] [Abstract][Full Text] [Related]
18. [Complex therapy of melanoma metastases in the lung].
Nivinskaia MM; Iavorskiĭ VV; Musatov VK; Ogurtsova IN
Med Radiol (Mosk); 1984 Feb; 29(2):7-10. PubMed ID: 6700393
[TBL] [Abstract][Full Text] [Related]
19. Cell detachment and metastasis.
Weiss L; Ward PM
Cancer Metastasis Rev; 1983; 2(2):111-27. PubMed ID: 6352010
[TBL] [Abstract][Full Text] [Related]
20. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones.
Sheppard JR; Koestler TP; Corwin SP; Buscarino C; Doll J; Lester B; Greig RG; Poste G
Nature; 1984 Apr 5-11; 308(5959):544-7. PubMed ID: 6323999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
